Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment

  • Paul Noble, Carlo Albera, Klaus-Uwe Kirchgaessler, Frank Gilberg, Ute Petzinger, Ulrich Costabel
  • European Respiratory Journal, September 2016, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.congress-2016.oa1809

The authors haven't yet claimed this publication.

Read Publication

In partnership with:

Link to European Respiratory Society (ERS) showcase